This enhanced GCG receptor activity, combined with the effects of GIP receptor engagement, is believed to contribute to the superior weight loss observed with this triple agonist
Zepbound is a brand-name tirzepatide medication that may be considered for chronic weight management in eligible patients when clinically appropriate
In tirzepatide therapy, it allows patients to gradually acclimate to the medication, enhancing tolerance and reducing common side effects
Its key for doctors to know these differences to choose the best treatment for their patients
Similarly, the homeostatic model assessment of insulin resistance (HOMA-IR) was calculated, indicating the presence of insulin resistance, which is characteristic of MASLD and a major driver of the disease
Add vegetables, seasoning, and optional turkey or salmon